As listed in Table 4, among the 101 patients with DPC, 12 had the SYNE1-rs9479297-TT genotype (11.8%, 95% coincidence interval 5.5–18.3%) and 89 had the non-TT genotype (72 and 17 for CC and CT genotypes, respectively), which was similar to the genotypic distribution of HCC/TCC DPC patients in the TES-analysis cohort (TT genotype, 33.3%, 95% coincidence interval 6.3–60.4%; Table 3). This evidence concerns the gene SYNE1 and hepatocellular carcinoma.